Journal article

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

IM Jacobson, MK Washington, M Buti, A Thompson, N Afdhal, R Flisiak, US Akarca, KG Tchernev, JF Flaherty, R Aguilar Schall, RP Myers, GM Subramanian, JG McHutchison, Z Younossi, P Marcellin, K Patel

Clinical Gastroenterology and Hepatology | ELSEVIER SCIENCE INC | Published : 2017

Abstract

Background & Aims Despite complete suppression of viral DNA with antiviral agents, in some patients with chronic hepatitis B (CHB), serum levels of alanine aminotransferase (ALT) do not normalize. We investigated factors associated with persistent increases in ALT level in patients with CHB given long-term tenofovir disoproxil fumarate. Methods We analyzed data from 471 hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients with CHB participating in 2 phase 3 trials. We identified patients with an increased level of ALT (above the upper limit of normal range) after 5 years (240 weeks) of tenofovir disoproxil fumarate therapy. We analyzed findings from liver biopsy specimens colle..

View full abstract